These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3583383)

  • 1. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.
    IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenicity of anticancer drugs and especially alkylating agents.
    Schmähl D
    IARC Sci Publ; 1986; (78):29-35. PubMed ID: 3583394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carcinogenicity of anticancer agents].
    Hayashi Y; Takahashi M; Yoshimura H
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in the carcinogenicity of anticancer agents.
    Prejean JD; Montgomery JA
    Drug Metab Rev; 1984; 15(3):619-46. PubMed ID: 6386411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
    Schmähl D
    Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinogenic effects of antineoplastic and immunosuppressive agents].
    Brock N; Schneider H
    Arzneimittelforschung; 1971 Sep; 21(9):1406-10. PubMed ID: 5171799
    [No Abstract]   [Full Text] [Related]  

  • 7. [The cancerogenicity of antineoplastic agents].
    Rieche K
    Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118
    [No Abstract]   [Full Text] [Related]  

  • 8. Second neoplasm--a complication of cancer chemotherapy.
    Chabner BA
    N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignancies induced by drug therapy: a review.
    Penn I
    IARC Sci Publ; 1986; (78):13-27. PubMed ID: 3294589
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the International Symposium on Water Metabolism. Festschrift, 600th anniversary of the University of Heidelberg. November 1985, Heidelberg, Federal Republic of Germany.
    Kidney Int Suppl; 1987 Aug; 21():S1-116. PubMed ID: 3476799
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary changes caused by cytostatic drugs].
    Akoun G; Milleron B; Mayaud C
    Ann Med Interne (Paris); 1985; 136(8):671-6. PubMed ID: 3914227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of adjuvant chemotherapy.
    Gürtler R
    Arch Geschwulstforsch; 1978; 48(7):644-52. PubMed ID: 736745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ophthalmologic side effects of the use of cytostatic agents].
    Zaal MJ; Polak BC
    Ned Tijdschr Geneeskd; 1985 Oct; 129(40):1919-21. PubMed ID: 4069251
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of the cytostatic agents Bleomycin and Peptichemio.
    Stacher A; Baumgartner G; Höcker P
    Int J Clin Pharmacol; 1973 Apr; 7(2):238-45. PubMed ID: 4125956
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinogenicity of alkylating cytostatic drugs in animals.
    Berger MR
    IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenicity of alkylating cytostatic drugs: conclusions and directions for future research.
    Kaldor J; Schmähl D
    IARC Sci Publ; 1986; (78):321-3. PubMed ID: 3583396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxic effects of cytostatic agents on the lung in monochemotherapy and polychemotherapy].
    Renovanz HD
    Wien Med Wochenschr; 1983 Apr; 133(7):159-67. PubMed ID: 6868616
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA; Hall TC; Sherman CD; Savlov ED
    Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse events and those managements of alkylating agents].
    Matsuoka H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():139-42. PubMed ID: 25831738
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumour alkylating agents: cytotoxic action and organ toxicity.
    Connors TA
    IARC Sci Publ; 1986; (78):143-5. PubMed ID: 3583387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.